Grimaud Brett A. 4
4 · Theravance Biopharma, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
Transactions
- Tax Payment
Ordinary Shares
[F1]2026-02-20$19.66/sh−20,833$409,577→ 334,449 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Signature
/s/ Brett A Grimaud|2026-02-24